Baseline thyroid assessment before initiating GLP-1 therapy is clinically prudent for patients with Hashimoto's disease and should include thyroid-stimulating hormone (TSH) and free thyroxine (T4) levels to ensure the patient's hypothyroidism is adequately controlled on their current levothyroxine dose
This approach is grounded in the understanding that despite sharing a therapeutic class, individual GLP-1 RAs can exhibit diverse biological effects and safety profiles due to their distinct molecular structures and mechanisms of action [1,4,5,6]
Combining semaglutide (a GLP-1 receptor agonist) with phentermine (a sympathomimetic) is not FDA-approved as a formal combination, but some providers explore this approach off-label based on differing mechanisms of action
Back Hoet, JP (1953) 'Gustave Eduoard Laguesse: His demonstration of the significance of the Islands of Langerhans', Diabetes , 2,4, 322-24
If vomiting persists, you cant keep fluids down, the injection area gets hot or painful after 48 hours, or you feel classic low-blood-sugar symptoms (sweating, confusion), reach outour team can adjust your dose or suggest additional relief so treatment stays smooth and effective